FDA Accepts Historical Controls for Epilepsy Monotherapy Studies

Researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs (AEDs) provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy.

Read the whole article on Science Daily

More from Science Daily